Myeloid DLL4 Does Not Contribute to the Pathogenesis of Non-Alcoholic Steatohepatitis in Ldlr-/- Mice
Non-alcoholic steatohepatitis (NASH) is characterized by liver steatosis and inflammation. Currently, the underlying mechanisms leading to hepatic inflammation are not fully understood and consequently, therapeutic options are poor. Non-alcoholic steatohepatitis (NASH) and atherosclerosis share the...
Main Authors: | Jeurissen, Mike L. J., Walenbergh, Sofie M. A., Houben, Tom, Hendrikx, Tim, Li, Jieyi, Oligschlaeger, Yvonne, van Gorp, Patrick J., Gijbels, Marion J. J., Bitorina, Albert, Nessel, Isabell, Radtke, Freddy, Vooijs, Marc, Theys, Jan, Shiri-Sverdlov, Ronit |
---|---|
Format: | Online |
Language: | English |
Published: |
Public Library of Science
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5127569/ |
Similar Items
-
MSP is a negative regulator of inflammation and lipogenesis in ex vivo models of non-alcoholic steatohepatitis
by: Chanda, Dipanjan, et al.
Published: (2016) -
Macrophage Stimulating Protein Enhances Hepatic Inflammation in a NASH Model
by: Li, Jieyi, et al.
Published: (2016) -
Weekly Treatment of 2-Hydroxypropyl-β-cyclodextrin Improves Intracellular Cholesterol Levels in LDL Receptor Knockout Mice
by: Walenbergh, Sofie M. A., et al.
Published: (2015) -
Plasma cathepsin D correlates with histological classifications of fatty liver disease in adults and responds to intervention
by: Walenbergh, Sofie M. A., et al.
Published: (2016) -
Is Western Diet-Induced Nonalcoholic Steatohepatitis in Ldlr-/- Mice Reversible?
by: Lytle, Kelli A., et al.
Published: (2016)